Switch Maintenance Treatment in Locally Advanced or Metastatic Non-small Cell Lung Cancer with Egfr Activating Mutations and Stable Disease After First-line Chemotherapy

A selection of medicines used for Switch Maintenance Treatment in Locally Advanced or Metastatic Non-small Cell Lung Cancer with Egfr Activating Mutations and Stable Disease After First-line Chemotherapy is listed below, including Erlotinib. Products containing Erlotinib feature in this group. Prices and product details are shown for comparison.